Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by 2b7f6fabon Jul 30, 2020 8:33pm

159 Views

Post# 31347274

RE:Burning Questions...

Couple years ago during Ph1 I and Dr Lilge came out with his laser dosimetry device and subsequently gave the patents to TLT did you ever wonder why didn't someone from Theralase come up with this device? What are we paying the researchers at Theralase? Now researchers at RPCI have developed their own device and using Dr SM compound are proposing to use it for NSCLC. I find it interesting that it seems no Theralase research effort went into advancing this new indication. Let me know if I'm off base please.

Bullboard Posts

Spin Master and Jason Kelce partner on new Hatchimals release